Filters
reset allOther countries
Results: 1 to 13 of 13
Tests names and labs | Conditions | Genes, analytes, and microbes | Methods |
---|---|---|---|
RIMS1 - NGS including CNV analysis Centogene AG - the Rare Disease Company Germany | 1 | 1 |
|
Centogene AG - the Rare Disease Company Germany | 1886 | 1858 |
|
Centogene AG - the Rare Disease Company Germany | 777 | 770 |
|
Centogene AG - the Rare Disease Company Germany | 417 | 413 |
|
Invitae Inherited Retinal Disorders Panel Invitae United States | 486 | 293 |
|
Autosomal Dominant Cone-Rod Dystrophy via the RIMS1 Gene PreventionGenetics, part of Exact Sciences United States | 1 | 1 |
|
PreventionGenetics, part of Exact Sciences United States | 37 | 35 |
|
Baylor Genetics United States | 842 | 637 |
|
Retinopathy and Optic Atrophy NGS Panel Fulgent Genetics United States | 563 | 241 |
|
Fulgent Genetics United States | 1 | 1 |
|
Fulgent Genetics United States | 5129 | 4672 |
|
Fulgent Genetics United States | 56 | 29 |
|
Comprehensive Eye Disorders NGS Panel Fulgent Genetics United States | 1018 | 459 |
|
Results: 1 to 13 of 13
IMPORTANT NOTE: NIH does not independently verify information submitted to the GTR; it relies on submitters to provide information that is accurate and not misleading. NIH makes no endorsements of tests or laboratories listed in the GTR. GTR is not a substitute for medical advice. Patients and consumers with specific questions about a genetic test should contact a health care provider or a genetics professional.